Detalhe da pesquisa
1.
Pralsetinib in patients with RET fusion-positive non-small-cell lung cancer: A plain language summary of the ARROW study.
Future Oncol
; 20(6): 297-306, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37916501
Mostrar mais
Texto completo
2.
Bone Metastases, Skeletal-Related Events, and Survival in Patients With Metastatic Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors.
J Natl Compr Canc Netw
; 19(8): 915-921, 2021 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33878726
3.
Emerging drugs for small cell lung cancer: a focused review on immune checkpoint inhibitors.
Expert Opin Emerg Drugs
; 25(3): 353-366, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32683991
4.
Real-world comparison of immune checkpoint inhibitors in non-small cell lung cancer following platinum-based chemotherapy.
J Oncol Pharm Pract
; 26(3): 564-571, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-31238808
5.
NCCN Guidelines Insights: Small Cell Lung Cancer, Version 2.2018.
J Natl Compr Canc Netw
; 16(10): 1171-1182, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30323087
6.
NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018.
J Natl Compr Canc Netw
; 16(6): 693-702, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29891520
7.
Small Cell Lung Cancer.
Semin Respir Crit Care Med
; 37(5): 783-796, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27732999
8.
Personalized Therapy of Small Cell Lung Cancer.
Adv Exp Med Biol
; 890: 149-74, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26703804
9.
NCCN Working Group report: designing clinical trials in the era of multiple biomarkers and targeted therapies.
J Natl Compr Canc Netw
; 12(11): 1629-49, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25361808
10.
A Phase II Trial of Pevonedistat and Docetaxel in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer.
Clin Lung Cancer
; 25(2): 128-134, 2024 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37977950
11.
Smoking status and survival in the national comprehensive cancer network non-small cell lung cancer cohort.
Cancer
; 119(4): 847-53, 2013 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23023590
12.
Modern staging of small cell lung cancer.
J Natl Compr Canc Netw
; 11(1): 99-104, 2013 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23307985
13.
Small cell lung cancer.
J Natl Compr Canc Netw
; 11(1): 78-98, 2013 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23307984
14.
Systemic Therapy for Small-Cell Lung Cancer: ASCO-Ontario Health (Cancer Care Ontario) Guideline.
J Clin Oncol
; 41(35): 5448-5472, 2023 Dec 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37820295
15.
Patient-Reported Health-Related Quality of Life in KEYNOTE-604: Pembrolizumab or Placebo Added to Etoposide and Platinum as First-Line Therapy for Extensive-Stage SCLC.
JTO Clin Res Rep
; 4(11): 100572, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37954964
16.
Phase I study of vorinostat (suberoylanilide hydroxamic acid, NSC 701852) in combination with docetaxel in patients with advanced and relapsed solid malignancies.
Invest New Drugs
; 30(1): 249-57, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20686817
17.
First-line systemic therapy practice patterns and concordance with NCCN guidelines for patients diagnosed with metastatic NSCLC treated at NCCN institutions.
J Natl Compr Canc Netw
; 10(7): 847-56, 2012 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22773800
18.
Combination chemotherapy for relapsed small-cell lung cancer.
Lancet Oncol
; 17(8): 1033-1035, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27312052
19.
An evaluation of sotorasib for the treatment of patients with non-small cell lung cancer with KRASG12C mutations.
Expert Opin Pharmacother
; 23(14): 1569-1575, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36217844
20.
Cellular engagement and interaction in the tumor microenvironment predict non-response to PD-1/PD-L1 inhibitors in metastatic non-small cell lung cancer.
Sci Rep
; 12(1): 9054, 2022 05 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-35641540